Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Atherosclerosis × Dermatologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 42 Melanoma 23 Skin Neoplasms 12 Lymphoma, T-Cell, Cutaneous 8 Carcinoma, Basal Cell 8 Mycosis Fungoides 5 Keratosis 4 Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uveal Melanoma 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Carcinoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Skin Diseases 1 Seroma 1 Renal Transplant Patients at High-risk for Skin Cancer 1 Psoriasis 1 Pituitary Neoplasms 1 Pituitary ACTH Hypersecretion 1 Photosensitivity Disorders 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain, Postoperative 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Lymphoma, T-Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06785974 2025-01-22

SPIRAL

Erasmus Medical Center

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡